Skip to content
Blackberry Empire – Lifestyle
Author:
Zealand Pharma
Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
September 18, 2026
Zealand Pharma – Transactions related to share buy-back program (week 37, 2026)
September 14, 2026
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
September 10, 2026
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
September 9, 2026
Zealand Pharma – Transactions related to share buy-back program (week 36, 2026)
September 7, 2026
Correction: Zealand Pharma – Transactions related to share buy-back program (week 35, 2026)
September 2, 2026
Zealand Pharma – Transactions related to share buy-back program (week 35, 2026)
August 31, 2026
Zealand Pharma – Notification of holding of treasury shares
August 29, 2026
Zealand Pharma – Transactions related to share buy-back program (week 34, 2026)
August 29, 2026
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
August 28, 2026
1
2
3
…
6
Next Page
→